Effects of Shengjiangxiexin decoction on irinotecan-induced toxicity in patients with UGT1A1*28 and UGT1A1*6 polymorphisms

被引:0
|
作者
Deng Bo [1 ]
Jia Liqun [1 ]
Tan Huangying [1 ]
Lou Yanni [1 ]
Li Xue [1 ]
Li Yuan [1 ]
Yu Lili [1 ]
机构
[1] China Japan Friendship Hosp, Integrat Oncol Dept, Beijing 100029, Peoples R China
关键词
UGT1A1; enzyme; Diarrhea; Irinotecan; Shengjiangxiexin decoction; COLORECTAL-CANCER PATIENTS; INDUCED DIARRHEA; OXALIPLATIN; UGT1A;
D O I
暂无
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
OBJECTIVE: To evaluate the efficacy of Shengjiangxiexin decoction (SXD), prepared with a formula from Traditional Chinese Medicine (TCM), in reducing irinotecan-induced hematological and gastrointestinal toxicities in patients with UDP-glucuronosyltransferase (UGT)1A1*28 and UGT1A1*6 polymorphisms. METHODS: This clinical trial included 115 patients receiving irinotecan combined with 5-fluorouracil plus 1-leucovorin (FOLFIRI) treatment. All patients consented to UGT1A1*28 and *6 gene polymorphism detection prior to chemotherapy. SXD were administered from 1 day prior to chemotherapy to 6 day post chemotherapy. Chemotherapy induced adverse reactions (neutropenia, diarrhea, nausea, vomiting, anorexia and infection) were recorded, and short-term effect of chemotherapy was evaluated regularly." RESULTS: A total of 50 patients had *1/*1 wild genotype, 58 patients had single allele variants with genotype *1/*6 or *1/*28, and 7 patients had two alleles variants with genotype *6/*6, *28/*28 or *61* 28. In *1/*6 or *1/*28 patients (high risk group),.9 patients (15.5%) developed I II grade diarrhea and no patient developed severe diarrhea; neutropenia occurred in 19 patients (32.8%) and only 3 patients (8.6%) developed sever neutropenia. There were no significant differences in any toxic effects (neutropenia, diarrhea, nausea, vomiting, anorexia or infection) between *6 or *28 variant patients (high risk group) and wild type patients. No sever toxicity was found in high risk two alleles variants patients (*6/*6, *6/*28 or *28/*28). No significant differences were observed between UGT1A1*6/*28 polymorphisms and clinical response of chemotherapy. CONCLUSION: SXD could significantly reduce irinotecan-induced hematological and gastrointestinal toxicities in UGT1A1*28 or *6 variant patients (high risk group), while this treatment didn't affect clinical response of chemotherapy. (C) 2017 JTCM. All rights reserved.
引用
收藏
页码:35 / 42
页数:8
相关论文
共 50 条
  • [41] UGT1A1*6/*28 polymorphisms could predict irinotecan-induced severe neutropenia not diarrhea in Chinese colorectal cancer patients
    Jing Gao
    Jun Zhou
    Yanyan Li
    Ming Lu
    Ru Jia
    Lin Shen
    Medical Oncology, 2013, 30
  • [42] UGT1A1*6/*28 polymorphisms could predict irinotecan-induced severe neutropenia not diarrhea in Chinese colorectal cancer patients
    Gao, Jing
    Zhou, Jun
    Li, Yanyan
    Lu, Ming
    Jia, Ru
    Shen, Lin
    MEDICAL ONCOLOGY, 2013, 30 (03)
  • [43] ROLE OF UGT1A1*6 IN IRINOTECAN TOXICITY IN JAPANESE CANCER PATIENTS
    Kakihata, K.
    Sai, K.
    Mori, A.
    Saito, Y.
    Suzuki, T.
    Ando, Y.
    Hasegawa, Y.
    Sawada, J.
    Yoshida, T.
    ANNALS OF ONCOLOGY, 2008, 19 : 50 - 50
  • [44] Re:: UGT1A1*28 genotype and irinotecan-induced neutropenia:: Dose matters -: Reply
    Hoskins, Janelle M.
    McLeod, Howard L.
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (03)
  • [45] Precision Medicine: UGT1A1 Genotyping to Better Manage Irinotecan-Induced Toxicity comment
    Carrato, Alfredo
    JCO ONCOLOGY PRACTICE, 2022, 18 (04) : 278 - +
  • [46] UGT1A1*6 polymorphisms are correlated with irinotecan-induced neutropenia: a systematic review and meta-analysis
    Zhang, Xue
    Yin, Jia-Fu
    Zhang, Jiao
    Kong, Shu-Jia
    Zhang, Hong-Yin
    Chen, Xue-Mei
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 80 (01) : 135 - 149
  • [47] UGT1A1*6 polymorphisms are correlated with irinotecan-induced neutropenia: a systematic review and meta-analysis
    Xue Zhang
    Jia-Fu Yin
    Jiao Zhang
    Shu-Jia Kong
    Hong-Yin Zhang
    Xue-Mei Chen
    Cancer Chemotherapy and Pharmacology, 2017, 80 : 135 - 149
  • [48] Association of UGT1A1*28 polymorphisms with irinotecan-induced toxicities in colorectal cancer: a meta-analysis in Caucasians
    Liu, X.
    Cheng, D.
    Kuang, Q.
    Liu, G.
    Xu, W.
    PHARMACOGENOMICS JOURNAL, 2014, 14 (02): : 120 - 129
  • [49] Association of UGT1A1*28 polymorphisms with irinotecan-induced toxicities in colorectal cancer: a meta-analysis in Caucasians
    X Liu
    D Cheng
    Q Kuang
    G Liu
    W Xu
    The Pharmacogenomics Journal, 2014, 14 : 120 - 129
  • [50] The role of UGT1A1 polymorphisms (☆28 and ☆6) in Japanese cancer patients
    Morimoto, S.
    Shimada, M.
    Kurita, N.
    Iwata, T.
    Nishioka, M.
    Yoshikawa, K.
    Miyatani, T.
    Mikami, C.
    Kashihara, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)